Ensign Peak Advisors, Inc Care Dx, Inc. Transaction History

Ensign Peak Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	BUY	$41.2 - $73.6 $445,372 - $795,615	10,810 New	10,810 $492,000
Q2 2021 Aug 13, 2021	SELL	$63.02 - $95.11 $1.22 Million - $1.84 Million	-19,313 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$57.62 - $95.6 $972,049 - $1.61 Million	-16,870 Reduced 46.62%	19,313 $1.32 Million
Q4 2020 Feb 12, 2021	BUY	$41.43 - $77.09 $360,813 - $671,376	8,709 Added 31.7%	36,183 $2.62 Million
Q3 2020 Nov 12, 2020	BUY	$30.88 - $37.94 $848,397 - $1.04 Million	27,474 New	27,474 $1.04 Million
Q1 2020 May 11, 2020	SELL	$13.94 - $28.25 $13,940 - $28,250	-1,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.24 - $28.41 $19,240 - $28,410	1,000 New	1,000 $22,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.